Symbicort combines budesonide, an inhaled corticosteroid, with formoterol, a bronchodilator. It is used in selected asthma and COPD treatment plans, with the strength and schedule determined by the condition. Some asthma plans specifically use budesonide/formoterol for both maintenance and symptom relief; others prescribe scheduled maintenance with a separate reliever.
Our team reviews your diagnosis, symptoms, current inhalers and written action plan before prescribing. We can assess an established regimen, review a repeat supply and help coordinate medication purchase. Follow-up checks control, technique, side effects and whether you understand the exact role of the inhaler supplied.
Severe breathing difficulty, trouble speaking, blue lips, marked exhaustion or symptoms not responding to your action plan requires emergency care. Do not create an extra-puff schedule from general information; follow the written plan for your prescribed inhaler.
What the combination does
Budesonide reduces airway inflammation, while formoterol relaxes airway muscle. Together they address different parts of breathing control. The combination is not equivalent to a bronchodilator-only inhaler, and its role depends on the prescribed plan rather than the fact that relief may be felt after a dose.
For asthma, the treatment choice reflects age, symptoms, exacerbation history and prior therapy. In selected circumstances, an inhaled corticosteroid-formoterol strategy is used for symptom relief as well as maintenance. That approach requires specific instructions, suitable presentation and daily limits rather than a general assumption that every combination inhaler can be used this way.
COPD treatment follows a different assessment and may use a different strength. The 80 mcg/4.5 mcg presentation displayed here should not be treated as a universal COPD product. We confirm the exact indication, device and strength before supply so that the pictured pack does not become a substitute for a prescribing decision.
| Treatment detail | What it means for your care |
|---|---|
| Main use | Maintenance treatment for asthma and selected COPD treatment |
| How it fits treatment | Budesonide provides inhaled corticosteroid treatment and formoterol opens the airways |
| Available formulation | Inhalation aerosol |
| Important review | The prescribed strength, device and written plan determine how the inhaler is used |
Assessment before prescribing
Tell us about daytime symptoms, nighttime waking, exercise limitation, reliever use and recent attacks. Bring lung function results, previous hospital or urgent care information and any oral steroid courses. We also ask about smoking, vaping and relevant occupational or home exposures.
Bring every inhaler and the written action plan. We check ingredients, dose and technique rather than assume that a list of brand names fully explains treatment. If asthma and COPD have not been clearly distinguished, an examination or further lung testing may be needed before choosing a combination inhaler.
Tell us about heart rhythm problems, glaucoma, cataracts, osteoporosis, diabetes, thyroid disease and infections such as tuberculosis. Pregnancy and breastfeeding also forms part of the review. A new medicine or health condition can change suitability even when the inhaler was previously well tolerated.
- Bring every inhaler you use, including a separate reliever if prescribed.
- Show us your technique and describe night waking or exercise symptoms.
- Confirm whether your written plan includes ICS-formoterol relief use.
Symbicort price and medication purchase
The cost depends on brand or generic supply, strength, device and quantity. The product beside this article is a budesonide/formoterol pressurized inhalation aerosol. Other devices and dose expressions need their own instructions and should not be substituted solely because the ingredient names match.
For a market reference, discounted pharmacy listings for generic budesonide/formoterol 80 mcg/4.5 mcg inhalation aerosol range from approximately $171.36 to $254.56 for a 10.2 g inhaler. This reference concerns that strength and presentation, not a higher-strength or dry powder product.
Retail prices are estimates and may change frequently. Consultation charges are separate from medication purchase. We confirm the prescribed product and medication charge before supply. If cost prompts a device change, we review technique and the action plan so that the new pack is used correctly.
Understanding your written inhaler plan
Your instructions should state whether the inhaler is scheduled maintenance only or part of a maintenance-and-reliever asthma plan. They should also identify the strength, regular dose, any permitted additional doses, daily limit and when to seek help. Do not borrow instructions from another patient's inhaler plan.
If the prescription includes a separate reliever, keep it available and use it as directed. If budesonide/formoterol itself is the prescribed reliever, follow that specific plan and do not add overlapping bronchodilators without review. Not every inhaled corticosteroid combination supports the same strategy.
Contact us if the label and the action plan appear to disagree. A generic substitution or hospital change can create confusion that deserves clarification before use. We can reconcile the instructions with the treating team rather than leave you to decide from the brand name or an online comparison.
Pressurized inhaler technique
Follow the leaflet for the exact device, including shaking and priming. A pressurized inhaler generally requires a slow inhalation coordinated with actuation, which differs from many dry powder devices. Ask for a demonstration and a technique check, particularly when changing from another inhaler system.
After prescribed doses containing corticosteroid, rinse the mouth and spit out the water as instructed. This helps reduce oral thrush and local irritation. If a spacer is appropriate for the supplied device and your needs, the pharmacist or clinician can explain its correct use rather than assume it works identically with every inhaler.
Keep the mouthpiece clean and check the dose counter. Do not use an unrelated actuator or attempt to alter the canister. Difficulty coordinating a dose, cough immediately after use or uncertainty about whether medicine reached the lungs is a reason to review technique before increasing treatment.
Control, reliever demand and flare-ups
Record symptoms, night waking and additional treatment used under the action plan. Increasing reliever demand or diminishing benefit warrants review, even when the inhaler still provides temporary relief. We consider adherence, technique, triggers, infection and whether the diagnosis or treatment needs reassessment.
An action plan should distinguish a mild increase in symptoms from a dangerous attack. Severe breathlessness, difficulty speaking or symptoms that do not improve as instructed requires emergency care. Do not continue taking repeated unplanned doses while waiting for a routine online reply.
Do not abruptly stop regular oral steroid treatment when starting an inhaled corticosteroid without a clinician-directed plan. Some patients need a gradual transition and monitoring. Bring the previous dose and duration so the change can be coordinated with the team managing the underlying condition.
Thrush, voice changes and other effects
Oral thrush, hoarseness, throat irritation or cough can occur. Rinsing and spitting and correct technique can help, but persistent soreness, white patches or voice changes deserve assessment. Do not simply abandon controller treatment without discussing a replacement plan for the breathing condition.
Formoterol can cause tremor, headache or palpitations. Severe chest pain, fainting or a sustained irregular heartbeat needs urgent assessment. Rarely, breathing worsens immediately after inhalation; follow urgent advice and do not continue the same device without assessment if paradoxical bronchospasm is suspected.
Longer-term inhaled corticosteroid exposure may affect eyes, bones or other systems in susceptible patients. We review the lowest effective regimen and relevant monitoring according to risk. A useful review balances control with adverse effects rather than assume an inhaled treatment has no systemic considerations.
Interactions and duplicate inhalers
Tell us about other long-acting bronchodilators, including ingredients hidden in combination devices. An additional LABA should not be added without a specific prescribing decision. A different brand name can still duplicate formoterol or another medicine with similar effects.
Certain antifungals, antiviral medicines and other strong CYP3A4 inhibitors can increase corticosteroid exposure. Beta blockers, diuretics and medicines affecting rhythm or potassium also need review. Include occasional treatments, because a short antibiotic or new pain medicine may still change safety during a flare.
If several clinicians prescribe inhalers, bring the actual devices to a medication review. We can clarify which one continues, which one has been replaced and how the reliever is intended to work. This helps prevent an older inhaler remaining in use alongside a new combination by mistake.
Infection, pregnancy and longer-term monitoring
Fever, changing sputum, chest pain or worsening breathlessness needs assessment for infection or another cause. In COPD, inhaled corticosteroids can increase pneumonia risk. A symptom change should not automatically lead to extra doses without considering the reason control has deteriorated.
Tell us about pregnancy plans or a new pregnancy. Maintaining good respiratory control remains important, and treatment should be reviewed as a whole rather than stopped without an alternative. We can coordinate with maternity or specialist care when needed.
Longer-term review includes relevant eye and bone concerns, growth monitoring in children where appropriate and the cumulative effect of other steroid medicines. Include nasal sprays, creams and oral courses in the history. The aim is suitable ongoing treatment with enough monitoring to identify a problem early.
Repeat prescriptions and device changes
For a refill, provide the exact strength and device, regular schedule, any additional doses used under the plan and the response. Tell us about recent attacks, hospital care or a new medicine. These details matter even when you are requesting the same brand as before.
Selected stable treatment can be reviewed online with adequate information. Poor control, uncertain diagnosis or new breathing symptoms may require an examination or lung testing. We explain the next step before deciding whether continuing the same inhaler is appropriate.
When treatment remains suitable, we help coordinate medication purchase and confirm the action plan and next review. Request supplies before the counter runs low. If the pharmacy changes the device or presentation, check the instructions before first use rather than assume the same opening and inhalation steps apply.
Fitting treatment into everyday life
Tell us if work, caring responsibilities or the cost of inhalers makes the prescribed routine difficult. Missed maintenance doses and uncertainty about additional doses can both affect control. We can review a practical schedule and the supply needed for the exact action plan, including times when symptoms increase.
Keep the plan and inhaler accessible during travel or activity. A family member or carer can be involved when you want support, especially if they may need to help during a flare. They should know which device is the reliever and when emergency care is needed rather than rely on the color of an inhaler.
If the plan changes after hospital care, bring the discharge instructions to follow-up. We reconcile the new schedule with older labels so that contradictory routines do not continue at home.
Common questions
Is Symbicort always maintenance-only treatment?
Its role depends on the written plan. Some asthma regimens prescribe suitable budesonide/formoterol products for both maintenance and relief, while other plans use scheduled maintenance and a separate reliever. Do not adopt additional doses without explicit instructions and limits for your own prescription.
Is the displayed strength suitable for every COPD patient?
No. COPD prescribing has its own assessment and strength selection. The pictured 80 mcg/4.5 mcg presentation is not a universal recommendation. We confirm the diagnosis, exact product and regimen before arranging a supply.
Can I continue Advair as well?
Do not combine inhalers containing overlapping long-acting bronchodilators without a specific review. Bring both devices and the latest instructions so the team can clarify which continues and which has been replaced. Different brand names do not prevent duplicate treatment.
Why does technique need checking after a generic change?
The medicine ingredients may match while the device steps or dose expression differ. A demonstration helps confirm that doses are prepared and inhaled correctly. We also check that the action plan still describes the product actually supplied.